RESSIE LOUIS: Open Payments
NPI 1245873371 · SUMMERVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$657 in 30 payments from 11 companies in 2025. Trend: 2023 $520 · 2024 $570 · 2025 $657
Food & beverage: $657
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 7 | $242 |
| Sage Therapeutics, LLC | 3 | $91 |
| Exeltis, USA Inc. | 4 | $77 |
| OptumHealth Care Solutions, LLC | 3 | $52 |
| MILLICENT US INC | 2 | $38 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $34 |
| Novo Nordisk Inc | 1 | $31 |
| MAYNE PHARMA COMMERCIAL LLC | 5 | $27 |
| Daiichi Sankyo Inc. | 1 | $25 |
| Exact Sciences Corporation | 1 | $21 |
Products named: Veozah, ZURZUVAE, SLYND, VIVIFY HEALTH CARE TEAM PORTAL 001, INTRAROSA, Mirena, Wegovy, INJECTAFER.
Industry payments across SC — which companies pay providers there.
